Advance your expertise in one of the most transformative frontiers of modern medicine. The Level 7 Diploma in Biomedical Science: Genomics and Precision Medicine offers rigorous postgraduate training for clinical scientists, biomedical professionals, and innovators in data-driven healthcare.
All course content is shaped by real-world breakthroughs from global pharmaceutical leaders, including Novartis, BioNTech, Roche, and Illumina, and grounded in the research of world-class faculty trained at or affiliated with institutions such as Oxford, Harvard, Yale, MIT, and leading organisations including the NIH, NHS Genomic Medicine Service, and NASA.
You will explore foundational discoveries, including those recognised by the Nobel Prize in Physiology or Medicine, while developing practical expertise relevant across both U.K. and U.S. genomics ecosystems. This dual focus equips graduates for impactful roles in clinical, academic, and translational settings.
Delivered through a flexible hybrid model:
Whether you aim to lead innovation, pursue doctoral research, or contribute meaningfully to precision health, this diploma delivers the knowledge, tools, and strategic insight to lead.
For full programme details: courses@oxfordacademy.io
The programme consists of four core modules and two optional modules, providing a rigorous yet flexible foundation in genomic and precision medicine. This structure allows students to develop core competencies while tailoring their learning to areas of individual interest. To reinforce analytical and communication skills, all learners also complete a 1,000-word research-style article, designed to deepen subject mastery through critical engagement with contemporary topics in genomic science and personalised healthcare.
Delivered through a hybrid format, the programme combines academic depth, practical training, and career-focused development. Key components include:
The curriculum is continuously updated to reflect current research, international policy developments, and emerging clinical frameworks. Learners will engage with milestone scientific advances, including those recognised by the Nobel Prize in Physiology or Medicine, while developing applied expertise relevant across U.K. and U.S. genomic healthcare systems.
Note: Faculty affiliations reflect individual academic and professional experience and do not imply institutional endorsement.
A globally recognised postgraduate qualification, and a launchpad for leadership in genomic medicine
The Level 7 Diploma in Biomedical Science: Genomics and Precision Medicine offers postgraduate-level training for professionals seeking to deepen their understanding of one of the most advanced areas in modern healthcare.
This qualification is aligned with Level 7 of the U.K. Regulated Qualifications Framework, corresponding academically to the first year of a master’s degree. It is internationally recognised and designed for clinicians, biomedical scientists, and researchers who are looking to strengthen both their theoretical knowledge and applied skills in genomic and precision medicine.
The programme is rigorous but flexible, enabling students to balance professional commitments while engaging with up-to-date research, case studies, and practical tools. Whether you intend to pursue doctoral study, transition into a leadership role, or enhance your contribution to clinical or research settings, this diploma provides a strong academic and professional foundation, delivered by faculty with experience at institutions such as Harvard, Oxford, MIT, Yale, the NHS Genomic Medicine Service, the National Institutes of Health (NIH), and NASA.
Each student becomes a named contributor to a professionally published volume focused on cutting-edge topics in genomics and personalised medicine. This collaborative research project is guided by faculty trained at, or currently affiliated with, institutions such as Oxford, Harvard, NHS Genomics, and MIT, giving learners early authorship on work that aligns with academic publishing standards.
Students collaborate with peers and with faculty who have been trained at, or are currently affiliated with, institutions such as Yale, Oxford, MIT, the NIH, and other global centres of excellence. Together, they plan and deliver a live online conference showcasing research and clinical insights in genomics and personalised healthcare. The event offers meaningful academic visibility and international engagement.
A prestigious, high-impact academic competition where students solve real-world clinical cases using genomic tools, patient scenarios, and data interpretation.
Submissions are peer-reviewed and evaluated by academics from Harvard, MIT, and NHS research centres.
Finalists receive:
Students critically explore landmark case studies, including breakthroughs awarded the Nobel Prize in Physiology or Medicine, and apply them to real diagnostic and therapeutic frameworks, bridging theory with practice in high-stakes decision-making.
Every student is assigned a dedicated career coach to support applications to PhD and clinical training programmes, advise on job readiness and academic publishing, and provide tailored professional guidance based on career goals in industry, healthcare, or research.
Whether you’re looking to publish your first paper, lead with confidence, compete at the highest academic level, or step into a research-intensive or clinical leadership role, this Level 7 Diploma offers more than academic credit: it’s a platform to accelerate your impact in the fast-evolving world of genomic and precision medicine. Guided by world-class faculty and shaped by real-world relevance, this programme is not just about what you learn; it’s about where it can take you. To explore how this diploma compares to traditional postgraduate routes, click here.
For students who wish to earn a full master’s degree, the diploma offers formal entry into the second year of the online MSc in Precision Medicine. This advanced track focuses entirely on independent research and publication and can be completed 100% online from anywhere in the world. For more information, please contact us at courses@oxfordacademy.io
You’ll study the following compulsory modules.
This course introduces learners to the foundational principles of human genetics and genomics, with a particular focus on how these concepts inform our understanding of cancer. Through a blend of scientific theory and real-world clinical insight, students will explore how genetic variation contributes to disease susceptibility, prognosis, and the development of precision oncology strategies. The course draws on high-impact research from across the world and equips students with the tools to critically interpret genomic data relevant to oncology and human health.
This course explores the rapidly evolving interface between pharmacogenomics, clinical trial innovation, and personalised drug design. It offers a deep, research-informed understanding of how genetic variation shapes drug response, therapeutic efficacy, and adverse event risk across diverse populations. Learners will examine how insights from AI, multi-omics, and real-world clinical datasets are revolutionising trial design and accelerating drug discovery, from cancer immunotherapy to neurology and cardiovascular precision medicine
This course offers an advanced and inspiring exploration of omics technologies, genomics, transcriptomics, proteomics, and metabolomics, through the lens of cutting-edge cancer research and therapy. Learners will investigate how high-throughput sequencing, CRISPR genome editing, AI-powered bioinformatics, and synthetic biology are revolutionising cancer diagnostics, prognostics, and personalised therapies. Inspired by the groundbreaking work of world-leading scientists and Nobel Laureates, this programme is designed for students, researchers, clinicians, and innovators eager to connect emerging omics technologies with real-world cancer solutions.
This course explores the transformative role of artificial intelligence (AI) across the biomedical and clinical field, equipping learners with deep, interdisciplinary insights into how AI technologies are revolutionising diagnostics, therapy design, and patient care. Through a comprehensive and forward-looking curriculum, students will examine the intersection of machine learning, digital health, and translational medicine, engaging with real-world data and frontier applications in precision healthcare. Inspired by leading research from globally recognised institutions and thought leaders, this course is designed for scientists, clinicians, engineers, entrepreneurs, and policy professionals committed to understanding and shaping the AI-driven future of healthcare.
You’ll study the following optional modules.
This course introduces learners to the core principles and applied methods of big data and genomic analytics in precision medicine. Through a combination of scientific theory, computational technologies, and clinical insight, students explore how large-scale genomic and health data drive personalised diagnosis, prognosis, and therapy. Inspired by pioneering work from the NIH, Broad Institute, Stanford, MD Anderson Cancer Center, and Karolinska Institute, the programme equips learners with advanced skills to lead in the future of AI-powered medicine.
This course explores how cutting-edge genomic technologies and artificial intelligence are revolutionising the understanding, treatment, and prevention of infectious diseases and cancer. Focusing on the interplay between pathogen genomics, immune system dynamics, and microbial ecosystems, the programme equips learners to tackle global health challenges with tools from onco-immunology, bioinformatics, synthetic biology, and precision public health. Designed for researchers, clinicians, bioengineers, and innovators, the course connects core scientific principles with real-world therapeutic interventions, spanning vaccine development, outbreak prediction, antimicrobial resistance (AMR), and personalised microbiome modulation.
This course investigates the transformative biomedical insights emerging from spaceflight environments, with a focus on human health, cancer biology, genomics, and regenerative medicine. From epigenetic shifts under microgravity to AI-guided astronaut health monitoring, learners will explore how space research is shaping the future of terrestrial and space-bound medicine. The programme is ideal for life sciences students, biomedical engineers, genomics researchers, and clinicians interested in the interface between extreme environments, molecular biology, and digital health.
This course explores the complex genomic, epigenetic, and bioethical landscape of rare genetic disorders, with an emphasis on psycho-oncological implications and precision therapeutics. Learners will investigate how single-gene mutations, imprinting errors, epigenetic dysregulation, and multi-omics profiles contribute to disease manifestation, mental health outcomes, and therapeutic responsiveness. Designed for advanced students, researchers, and clinical professionals, this course links breakthroughs in human genetics to the psychological, social, and diagnostic dimensions of rare inherited diseases.
This course explores the convergence of next-generation genomic technologies, artificial intelligence (AI), and the ethical, legal, and social implications (ELSI) that shape their application in cancer research and clinical practice. Learners will gain deep, research-led understanding of how tools like CRISPR, single-cell sequencing, graph-based genome assembly, and liquid biopsy are transforming diagnosis and personalised oncology. Unlike traditional programmes, this course empowers students not only as analysts but as global leaders. Participants will examine regulatory frameworks, social equity, and emerging controversies, such as gene editing ethics, AI bias, and global genomic justice. Through immersive case simulations and innovation pitch opportunities, students are challenged to design solutions to real-world ethical or clinical dilemmas.
As part of the programme, each student will develop a 1,000-word scientific article exploring a topic of personal interest within genomics, precision medicine, or biomedical science. Articles may be selected for inclusion in a professionally curated publication produced by the Oxford Academy of Excellence — offering students the opportunity to showcase original thought and contribute meaningfully to the wider scientific and educational community. This experience not only cultivates high-level scientific communication and critical thinking, but also results in a tangible, portfolio-worthy output that reflects academic rigour, depth of insight, and real-world relevance.
(Genomics and Precision Medicine).
Course Director
Dr. Detina Zalli is a senior academic in genomic medicine. Dr. Zalli, has worked at institutions like Harvard University, the University of Oxford, and at the University of Cambridge. She holds a PhD from the University of Leicester, conducted postdoctoral research at the Harvard School of Dental Medicine, and completed the NASA STAR program focused on designing spaceflight experiments. At Harvard, Detina conducted research and, earning the Dean’s Research Award for two years. Inspired by Barack Obama, she engaged in Harvard Professional Government activities.
Module Lead in Omics Technologies and Application in Genomic Medicine
Dr. Joseph “Sci” Borg is an investigator at NASA GeneLab, where he uses single cell sequencing and RNAseq analysis to study the molecular mechanisms of erythropoiesis and globin gene switching in space and terrestrial environments. He has been working in this field for over a decade and holds a PhD in molecular genetics from the University of Malta, as well as a visiting postdoctoral fellowship from Erasmus MC.
We welcome applicants from all backgrounds and nationalities, and assess each application on an individual basis. While prior academic experience in biomedical or life sciences is preferred, we also recognise professional or research experience where relevant. Our admissions process is designed to be inclusive, transparent, and aligned with international postgraduate standards.
A minimum of a 2:1 undergraduate degree (or international equivalent) in a medical, biomedical, or healthcare-related discipline is normally required.
However, in exceptional circumstances, applicants who do not meet this academic threshold may still be considered if they can demonstrate substantial and relevant professional experience in a closely related field. All applications are assessed holistically, taking into account academic background, work experience, and motivation for study.
All applicants must demonstrate an appropriate level of English language proficiency to successfully participate in the programme.
OAE expects a high standard of academic English, as required for advanced study in biomedical and healthcare subjects. This may be evidenced through previous academic study, professional experience, or other relevant qualifications.
We recognise a broad spectrum of international qualifications for postgraduate study at the Oxford Academy of Excellence. General guidance on how qualifications from public institutions overseas may meet our minimum academic admission requirements is provided in the country and region index below.
However, for specific information about course requirements, please refer to the relevant course pages or contact the Admissions Team at courses@oxfordacademy.io.
Please note that requirements and acceptability may vary depending on the type of institution.
Due to the rigorous and competitive nature of our programmes, individual departments, centres, or academic units may set admissions standards that are higher than the minimum requirements listed in our index.
We review and update our requirements annually, typically in September, before the start of the next academic year.
Home and Overseas students who an application to start the course in 2024.
All students applying to study a Faculty of Medicine Master’s programme beginning in October 2025
